Host: Marc Pelletier
Dr. Lifton has been on a quest to understand the genetic basis of hypertension, the most important risk factor associated with cardiovascular disease, which affects nearly a billion people worldwide. And since his discoveries have actually changed how doctors treat hypertension, it would be fair to say that his work has improved the lives of millions.
I think there is an important underlying story here, and it is not about the genetics of cardiovascular disease, but of scientific endeavor. There are some great challenges ahead of us, and no matter how complex the problem, we shouldn't be discouraged from taking them head on...
This episode of Futures in Biotech was sponsored by Invitrogen. Save 15% on selected High Fidelity PCR enzymes with the purchase of a Zero Blunt TOPO cloning kit, and other selected TOPO kits. See TOPO ZeroBackground high fidelity. Quote RTPCWU for US or RTPCWC for Canada when ordering.
Thanks to Cachefly for providing the bandwidth for this netcast.
Also thanks to Will Hall for the great opening and closing themes AND Matthew McInerney for the cool FiB Desktops.